These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 18339022

  • 41. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ.
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [Abstract] [Full Text] [Related]

  • 42. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN, Fritsche TR, Sader HS, Stilwell MG.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
    [Abstract] [Full Text] [Related]

  • 43. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [Abstract] [Full Text] [Related]

  • 44. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
    Sánchez C, Armengol R, Mir I, Lite J, Garau J.
    Enferm Infecc Microbiol Clin; 1992 May 15; 10(6):334-9. PubMed ID: 1391015
    [Abstract] [Full Text] [Related]

  • 45. Antibiotic susceptibility of Streptococcus pneumoniae in New Zealand.
    Brett W, Masters PJ, Lang SD, Ikram RB, Hatch SH, Gordon MS.
    N Z Med J; 1999 Mar 12; 112(1083):74-8. PubMed ID: 10210308
    [Abstract] [Full Text] [Related]

  • 46. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005.
    Sener B, Tunçkanat F, Ulusoy S, Tünger A, Söyletir G, Mülazimoğlu L, Gürler N, Oksüz L, Köksal I, Aydin K, Yalçin AN, Oğünç D, Acar A, Sievers J.
    J Antimicrob Chemother; 2007 Sep 12; 60(3):587-93. PubMed ID: 17597058
    [Abstract] [Full Text] [Related]

  • 47. Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan.
    Oishi K, Yoshimine H, Watanabe H, Watanabe K, Tanimura S, Kawakami K, Iwagaki A, Nagai H, Goto H, Kudoh S, Kuriyama T, Fukuchi Y, Matsushima T, Shimada K, Matsumoto K, Nagatake T.
    Respirology; 2006 Jul 12; 11(4):429-36. PubMed ID: 16771912
    [Abstract] [Full Text] [Related]

  • 48. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
    Jones RN, Sader HS, Fritsche TR.
    Diagn Microbiol Infect Dis; 2004 Jun 12; 49(2):147-9. PubMed ID: 15183865
    [Abstract] [Full Text] [Related]

  • 49. Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland.
    Clarke P, Murchan S, Smyth EG, Humphreys H.
    Clin Microbiol Infect; 2004 Jul 12; 10(7):657-9. PubMed ID: 15214880
    [Abstract] [Full Text] [Related]

  • 50. Resistance among Streptococcus pneumoniae: Implications for drug selection.
    Appelbaum PC.
    Clin Infect Dis; 2002 Jun 15; 34(12):1613-20. PubMed ID: 12032897
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Study on drug resistance and molecular epidemiology of Streptococcus pneumoniae isolated in Chongqing].
    Yao C, Yu ZB, Xiao YH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun 15; 26(6):431-4. PubMed ID: 16185457
    [Abstract] [Full Text] [Related]

  • 56. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
    Srifuengfung S, Tribuddharat C, Champreeda P, Daniels J, Chokephaibulkit K, Wongwan N, Polwichai P.
    Southeast Asian J Trop Med Public Health; 2008 May 15; 39(3):461-6. PubMed ID: 18564685
    [Abstract] [Full Text] [Related]

  • 57. Pneumococcal infections in Trinidad: patterns of antimicrobial susceptibility: 1994-2002.
    Orrett FA.
    Jpn J Infect Dis; 2005 Feb 15; 58(1):20-4. PubMed ID: 15728985
    [Abstract] [Full Text] [Related]

  • 58. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients].
    Stephan C, Just-Nübling G, Franck S, Bickel M, Shah PM, Babacan E, Staszewski S.
    Med Klin (Munich); 2008 Feb 15; 103(2):69-74. PubMed ID: 18270662
    [Abstract] [Full Text] [Related]

  • 59. Penicillin-resistant Streptococcus pneumoniae in Iran.
    Kohanteb J, Sadeghi E.
    Med Princ Pract; 2007 Feb 15; 16(1):29-33. PubMed ID: 17159361
    [Abstract] [Full Text] [Related]

  • 60. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.
    Lynch III JP, Martinez FJ.
    Clin Infect Dis; 2002 Mar 01; 34 Suppl 1():S27-46. PubMed ID: 11810608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.